financetom
Business
financetom
/
Business
/
Update: TD Bank Trading at Discount, Says Morningstar Financial Research
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: TD Bank Trading at Discount, Says Morningstar Financial Research
Jan 16, 2025 9:47 AM

12:24 PM EST, 01/16/2025 (MT Newswires) -- (The updated version includes the Morningstar rating and fair value estimate for TD Bank.)

TD Bank is trading at a discount to fair value estimates, notes Morningstar Financial Research, which has a four-star rating and fair value estimate of $88 on the stock.

The bank is well-capitalized, with a common equity Tier 1 ratio of 12.8% as of July 2024, well above the 11% minimum. "We view the company's capital investments as exemplary, as the bank has avoided value-destroying products and expansions while pursuing sensible investments and growth opportunities, allowing it to build up one of the most highly profitable Canadian banking franchises," says Morningstar equity analyst Michael Miller.

TD has also been raising dividends consistently over the past five years, reflecting a prudent capital allocation strategy. "We assess the company's capital return strategy as appropriate; it is largely in line with peers', with a healthy focus on a dividend and some additional earnings left over for repurchases after internal investments," Miller adds. The stock's fair value was recently lowered from $90 per share to $88, due to losses tied to anti-money-laundering issues.

Price: 79.44, Change: +0.13, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA greenlights first ever treatment for rare metabolic disorder
US FDA greenlights first ever treatment for rare metabolic disorder
Mar 26, 2025
March 26 (Reuters) - The U.S. Food and Drug Administration approved Soleno Therapeutics' ( SLNO ) drug to treat a rare genetic disorder on Wednesday, making it the first treatment available for patients who experience feelings of intense and persistent hunger. ...
Carlyle Secured Lending Shareholders Approve Merger With Carlyle Secured Lending III
Carlyle Secured Lending Shareholders Approve Merger With Carlyle Secured Lending III
Mar 26, 2025
05:06 PM EDT, 03/26/2025 (MT Newswires) -- Carlyle Secured Lending ( CGBD ) said its shareholders approved the merger with Carlyle Secured Lending III. At a special meeting, 96% of voting shareholders supported issuing common stock for the merger, which is expected to be finalized Thursday, the company said Wednesday in a statement. ...
Oppfi Insider Sold Shares Worth $2,869,855, According to a Recent SEC Filing
Oppfi Insider Sold Shares Worth $2,869,855, According to a Recent SEC Filing
Mar 26, 2025
05:09 PM EDT, 03/26/2025 (MT Newswires) -- Theodore G Schwartz, 10% Owner, Director, on March 24, 2025, sold 268,611 shares in Oppfi ( OPFI ) for $2,869,855. Following the Form 4 filing with the SEC, Schwartz has control over a total of 186,737 Class A common shares of the company, with 186,737 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1818502/000090514825001009/xslF345X05/form4.xml ...
Leonardo DRS Gets $16.9 Million Project From US Army
Leonardo DRS Gets $16.9 Million Project From US Army
Mar 26, 2025
05:10 PM EDT, 03/26/2025 (MT Newswires) -- Leonardo DRS ( DRS ) said Wednesday it secured a $16.9 million prototype project award from the US Army to upgrade the Paladin Electric Servo Amplifier electric weapon control system for the M109A7 Paladin self-propelled howitzer. Leonardo said it will design a prototype with current electrical technology to enhance the producibility and maintainability...
Copyright 2023-2026 - www.financetom.com All Rights Reserved